Citius Pharmaceuticals, Inc. company info

CIK 1506251
IRS Number 273425913
State of incorporation NV
Business address 11 COMMERCE DRIVE
1ST FLOOR
CRANFORD
NJ
07016
Mail address 11 COMMERCE DRIVE
1ST FLOOR
CRANFORD
NJ
07016

Short summary

Citius Pharmaceuticals, Inc. is a New Jersey company, with head office located at 11 Commerce Drive Cranford, New Jersey 07016. In 2018 the company owned a total of 25.54 million USD worth of assets, including 4.56 million USD worth of current assets. The company amassed the most assets last year, totalling up to 25.54 million USD.

Citius Pharmaceuticals, Inc. Income Statement

Name [in Millions USD]201020112012201320142015201620172018Trends
Cost of Goods and Services Sold 0.050.050.08
Research and development 0.710.490.001.802.932.946.56
Operating Expenses 0.031.021.180.653.237.459.9913.79
Operating Income (Loss) -0.03-1.02-1.18-0.65-3.23-7.45-9.99-13.79
Interest expense 0.000.030.110.090.010.010.850.02
Other Nonoperating Income (Expense) 0.350.46
Income Tax Expense (Benefit) 0
Net income -0.02-0.03-1.05-1.29-0.74-2.90-8.30-10.38-12.54

Citius Pharmaceuticals, Inc. Balance Sheet

Name [in Millions USD]201020112012201320142015201620172018Trends
Cash and cash equivalents 0.000.000.000.020.951.630.202.764.51
Property, Plant and Equipment, Gross 0.010.01
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.000.010.01
Goodwill 1.591.591.591.59
Total assets 0.000.000.0000.9623.0121.5723.8325.54
Current assets 0.000.000.0000.962.020.562.834.56
Accounts payable 0.000.000.000.000.330.311.980.912.43
Total current liabilities 0.020.040.060.032.144.859.972.194.04
Total liabilities 3.012.30
Common Stock, Value, Issued 0.020.020.020.020.030.070.010.010.02
Retained Earnings (Accumulated Deficit) -5.40-8.13-14.75-24.68-37.41-52.17

Citius Pharmaceuticals, Inc. Cash Flow

Name [in Millions USD]201020112012201320142015201620172018Trends
Net income -0.02-0.03-1.05-1.29-0.74-2.90-8.30-10.38-12.54
Depreciation and amortization 00.000.00
Depreciation 0.000.000.00
Accounts payable 0.000.070.08-0.070.450.11-0.310.97
Net Cash Provided by (Used in) Operating Activities -0.02-0.92-1.10-0.18-2.39-5.90-7.97-11.32
Payments to Acquire Property, Plant, and Equipment 0.00
Net Cash Provided by (Used in) Investing Activities 0-0.000.26-0.00
Proceeds from Issuance of Common Stock 00.500.05
Net Cash Provided by (Used in) Financing Activities 0.020.901.111.681.515.2610.8817.30
Cash and Cash Equivalents, Period Increase (Decrease) -0.00-0.020.011.50-0.88-0.382.915.98